NIH (not invented here)

One of the biotech industry's great strengths is its unity, a collective purpose that has resulted in remarkable collegiality among companies.

However, the response in some quarters to Scherer Healthcare's merger proposal to ProCyte Corp. (see page B2) reminds us that sometimes this sense of community also can be a weakness...